Evidence map›Paper›PMID 34749750›Full record

ArticleCell communication and signaling : CCS2021

STING protects against cardiac dysfunction and remodelling by blocking autophagy.

Rui Xiong, Ning Li, Lei Chen, Wei Wang, Bo Wang, Wenyang Jiang, Qing Geng

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. The potential role of hydrogen sulfide-autophagy axis in diseases.Journal of physiology and biochemistry · 2025
    Review
  7. Review
  8. Article
  9. Heart failure, inflammation and exercise.International journal of biological sciences · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rui Xiong *Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Ning Li *Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Lei Chen *Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China.
Wei WangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Bo WangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Wenyang JiangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China. whujwy0228@163.com.
Qing GengDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China. gengqingwhu@whu.edu.cn.ORCID 0000-0003-4515-5084
Wuhan University · CN

Funding

National Natural Science Foundation of China 81770095
6 · The paper itself

Abstract

backgroundHeart failure, which is characterized by cardiac remodelling, is one of the most common chronic diseases in the aged. Stimulator of interferon genes (STING) acts as an indispensable molecule modulating immune response and inflammation in many diseases. However, the effects of STING on cardiomyopathy, especially cardiac remodelling are still largely unknown. This study was designed to investigate whether STING could affect cardiac remodelling and to explore the potential mechanisms.

methodsIn vivo, aortic binding (AB) surgery was performed to construct the mice model of cardiac remodelling. A DNA microinjection system was used to trigger STING overexpression in mice. The STING mRNA and protein expression levels in mice heart were measured, and the cardiac hypertrophy, fibrosis, inflammation and cardiac function were also evaluated. In vitro, cardiomyocytes stimulated by Ang II and cardiac fibroblasts stimulated by TGF-β to performed to further study effects of STING on cardiac hypertrophy and fibroblast. In terms of mechanisms, the level of autophagy was detected in mice challenged with AB. Rapamycin, a canonical autophagy inducer, intraperitoneal injected into mice to study possible potential pathway.

resultsIn vivo, the STING mRNA and protein expression levels in mice heart challenged with AB for 6 weeks were significantly increased. STING overexpression significantly mitigated cardiac hypertrophy, fibrosis and inflammation, apart from improving cardiac function. In vitro, experiments further disclosed that STING overexpression in cardiomyocytes induced by Ang II significantly inhibited the level of cardiomyocyte cross-section area and the ANP mRNA. Meanwhile, TGF-β-induced the increase of α-SMA content and collagen synthesis in cardiac fibroblasts could be also blocked by STING overexpression. In terms of mechanisms, mice challenged with AB showed higher level of autophagy compared with the normal mice. However, STING overexpression could reverse the activation of autophagy triggered by AB. Rapamycin, a canonical autophagy inducer, offset the cardioprotective effects of STING in mice challenged with AB. Finally, further experiments unveiled that STING may inhibit autophagy by phosphorylating ULK1 on serine757.

conclusionsSTING may prevent cardiac remodelling induced by pressure overload by inhibiting autophagy, which could be a promising therapeutic target in heart failure. Video Abstract.

Indexed as

Angiotensin IIAnimalsApoptosisAutophagyAutophagy-Related Protein-1 HomologCardiomegalyDisease Models, AnimalGene Expression RegulationHeart FailureHumansMembrane ProteinsMiceMyocytes, CardiacProtective AgentsSignal TransductionSirolimusAngiotensin IIAutophagy-Related Protein-1 HomologMembrane ProteinsProtective AgentsSirolimusSting1 protein, mouseSTING ProteinUlk1 protein, mouseAutophagyCardiac remodellingInflammationSTINGULK1

Identifiers

PMID34749750
PMCPMC8576910
OpenAlexW3126288385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.